Popular Today
Popular Today
Popular All Time
StockGuild StockGuild PRO DCTH, 15, Long ,
DCTH: $DCTH Mid Term Goals could put this over $1+ In Weeks - Repost -
339 0 6
DCTH, 15 Long
$DCTH Mid Term Goals could put this over $1+ In Weeks - Repost -

Reposting as it didn't post properly the first time $DCTH Highlights for the first quarter of 2017 and the recent weeks include: First quarter 2017 revenue of $0.74 million, an increase of 100% compared with revenue of $0.37 million in prior year quarter. CHEMOSAT treatment milestone set by SPIRE Southampton Hospital in the U.K. with more than 100 CHEMOSAT ...

StockGuild StockGuild PRO ENDV, 30, Long ,
ENDV: $ENDV Alerted at .0150 Currently .0850 4th Major Leg up Starting
111 0 2
ENDV, 30 Long
$ENDV Alerted at .0150 Currently .0850 4th Major Leg up Starting

1. Won their Injunction 2. PreClinical Trials for its Immunotronics Platform 3. Filed for Orphan Drug Status 4. Over 20 patents 5. Form 4s filed by insiders 6. Converts being bought by Company and Institutions 7. Uplistment 8. President and CEO has been filing form 4's everyday so far the past couple weeks

StockGuild StockGuild PRO USRM, 30, Long ,
USRM: $USRM Alerted from .012 Currently on 3rd Major Breakout Setup
368 0 4
USRM, 30 Long
$USRM Alerted from .012 Currently on 3rd Major Breakout Setup

$USRM is currently awaiting RMAT designation which approved (And there is a 90% or higher chance it will) gives it similar qualities as Breakthrough Therapy, Accelerated Approval, and Priority Review. Basically, they can provisionally approve the drug or device for marketing and then provided the drug or device proves safe and reasonably effective, they will gain ...

TradeForProfits TradeForProfits PTLF, D, Long ,
PTLF: $PTLF #petcancer treatment potential with #Vitalzul. #FDA #CVM
46 0 2
PTLF, D Long
$PTLF #petcancer treatment potential with #Vitalzul. #FDA #CVM

$PTLF PetLife recent news indicates 1st step towards #FDA meeting and subsequent submission has been completed. 2 more studies coming up. Stock has come down and stabilized over the past month. Looks ready to head back up here. On watch for next study results.

TheHarveySpecter TheHarveySpecter FLXN, W, Long ,
FLXN: FLXN Long: Technical & Fundamentals
62 0 2
FLXN, W Long
FLXN Long: Technical & Fundamentals

Upcoming FDA decision and Fib retracement

United States
United Kingdom
Home Stock Screener Forex Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing Priority Support Ideas Published Followers Following Private Messages Chat Sign Out